Concepedia

Marek Psota

MP

Statistics

Publications

2

Citations

28

H-Index

2

Active since

2017

Affiliations

Institute of Experimental Pharmacology and Toxicology of the Slovak Academy of Sciences(Current)

Marek Psota is an author at Institute of Experimental Pharmacology and Toxicology of the Slovak Academy of Sciences specializing in pharmacoeconomic modeling, pharmacy, and glycemic targets.

ORCID

Publications per year

2017–2019

2

Publications

2

Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system

Marek Psota, M. Psenkova, Natalia Racekova et al. · ClinicoEconomics and Outcomes Research · 2017 · 14 citations · Full text

, , +17

The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia

Samuel J. P. Malkin, Monika Russel-Szymczyk, Marek Psota et al. · Advances in Therapy · 2019 · 14 citations · Full text

, , +17

1–2 of 2